Autoimmune Diseases Working Party (ADWP)
Type d'étude:
Numéro de l'étude:
2006-004598-83
Type de traitement à base de cellules souches:
Maladies:
Auto immune disorders
Titre court:
ASTIS
Objectif principal:
To evaluyate the potential clinical benefit of high dose immunoablation and autologous stem cell transplantation in comparison to intravenous pulse therapy cyclophosphamide, with respect to survival and prevention of major organ failure, safety, impact on skin thickening, visceral involvement, functional status and quality of life.
Principaux critères d'inclusion:
18-65 years
Pays:
Autriche
Belgique
Canada
France
Allemagne
Grèce
Italie
Pays-Bas
Suisse
Royaume Uni
Investigateur principal:
J.M. van Laar
Coordinateur EBMT de l'étude:
Ruzena Uddin